Skip to main content
. Author manuscript; available in PMC: 2011 Nov 15.
Published in final edited form as: Cancer Res. 2010 Nov 2;70(22):9185–9196. doi: 10.1158/0008-5472.CAN-10-1545

Figure 6. Akt regulates Casp9 RNA splicing in E746-A750 del EGFR-expressing HBEC-3KT cells.

Figure 6

A) RT-PCR analysis of Casp9 splice variants from E746-A750 EGFR-expressing HBEC3-KTs treated with LY294002 [50M], or LY303511 [50M], and B) Akt inhibitor VIII [25M] or 0.1% DMSO. C) RT-PCR analysis of Casp9 splice variants from E746-A750 EGFR-expressing HBEC3-KTs transfected with control siRNA, Akt1 siRNA, or Akt2 siRNA. Data are expressed as means ± S.E.